Перейти
на сайт журнала "Врач" |
Перейти на сайт журнала "Медицинская сестра"
|
Перейти на сайт журнала "Фармация"
|
Перейти на сайт журнала "Молекулярная медицина"
|
Перейти на сайт журнала "Вопросы биологической, медицинской и фармацевтической химии"
|
Журнал включен в российские и международные библиотечные и реферативные базы данных
ВАК (Россия)
|
РИНЦ (Россия)
|
Эко-Вектор (Россия)
|
INVESTIGATION OF RELEASE KINETICS OF DOXORUBICIN FROM DRUG CARRIER BASED ON Fe(0) MICROPARTICLES UNDER INFLUENCE OF ULTRASOUND IRRADIATION AND DIFFERENT VALUES OF pH
DOI: https://doi.org/10.29296/25877313-2019-05-03
Issue:
5
Year:
2019
Aim. To obtain new drug carrier for doxorubicin based on modified Fe(0) microparticles and evaluate its release kinetics under influence of differ-ent values of pH and ultrasound irradiation. Material and methods. Size and zeta-potential of microparticles were determined on Zetasizer Nano ZS. Surface modification (covalent binding of residues of benzoic acid) was confirmed by FTIR spectroscopy. Encapsulation efficiency (EE) and loading capaci-ty (LC) of doxorubicin (DOX) was determined by UV spectroscopy (480 nm). Release studies were carried out in Stuart SI 500 incubator at a constant temperature (37 °C), stirring rate (100 rpm) and different pH values (3.3; 5.5; 7.4). For investigation of influence of ultrasound (US) irradiation on the re-lease kinetics ultrasound field with frequency and power 75 kHz and 2 W/cm2 respectively was used. Ultrasonic bath Elmasonic S10H was used as a source of ultrasound irradiation. Results and discussions. Size and zeta-potential of Fe-CS-DOX conjugate were 4.43 and -9.07 respectively. Loading capacity of doxorubicin was 0.54 mg/mg. Percentage of released drug with and without US irradiation were 96 and 18% respectively (in 12 hours after starting of the experiment). Conclusion. In this study, the release of doxorubicin from drug carrier, based on Fe (0) microparticles at different pH values was investigated and the influence of ultrasound irradiation on the release kinetics was confirmed. In 12 hours after starting of the release, the amount of released drug was increased more than 4 times. So, the obtained conjugate Fe-CS-DOX leaves great promise for its further use as a drug carrier.
Keywords:
doxorubicin
chitosan
iron zero-valent microparticles
References:
- Liu F.S. Mechanisms of chemotherapeutic drug resistance in cancer therapy - A quick review // J. Obstet. Gynecol. 2009; 48:239-244.
- Prasanna N.R., Triveni C., Soumya R., Ramana B.V., Nagarahan G. Novel Delivery Systems in Cancer Chemotherapy // Research & Reviews in Pharmacy and Pharmaceutical Sciences. 2013; 2(1):8-19.
- Chen M., Xu A., He W., Ma W., Shen S. Ultrasound triggered drug delivery for mitochondria targeted sonodynamic therapy // J. Drug Deliv. Sci. Technol. 2017; 39:501-507.
- Deelman L.E., Decleves A.E., Rychak J.J., Sharma K. Targeted renal therapies through microbubbles and ultrasound // Advanced drug delivery reviews. 2010; 62(14):1369-1377.
- Crane N.B. Strengthening Porous Metal Skeletons by Metal Deposition From a Nanoparticle Dispersion. Massachusetts Institute of Technology. Dept. of Mechanical Engineering. Massachusetts., 2006. 237 p.
- Filimonov V.D., Trusova M.E., Postnikov P.S., Krasnokutskaya E.A., Lee Y.M., Hwang H.Y., Kim H., Chi K-W. Unusually Stable, Versatile, and Pure Arene diazonium Tosylates: Their Preparation, Structures, and Synthetic Applicability // Org. Lett. 2008; 10:3961–64.
- Guselnikova O.A., Galanov A.I., Gutakovskii A.K., Postnikov P.S. The convenient preparation of stable aryl-coated zerovalent iron nanoparticles // Beilstein J. Nanotechnol. 2015; 6:1192-1198.
- Di Martino A., Guselnikova O.A., Trusova M.E., Postnikov P.S., Sedlarik V. Organic-inorganic hybrid nanoparticles controlled delivery system for anticancer drugs // Int. J. Pharm. 2017; 526(1-2):380-390.
- Chehimi M.M., Lamouri A., Picot M., Pinson J. Surface modification of polymers by reduction of diazonium salts: polymethylmethacrylate as an example // J. Mater. Chem. C. 2014; 2:356–363.